| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On July 22, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1996P-0230
|
| Grant exception for label declaration of ingredients/b olive
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutritin
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2000V-1247
|
| Laser Light Show
|
|
|
|
|
| 2003P-0176
|
| Follow-Up Approval of Therapeutic Protein Products
|
|
|
|
|
| 2004N-0382
|
| Food Labeling: Safe Handling Statements: Labeling of Shell Eggs
|
|
|
|
|
| 2004P-0110
|
| Nutrient Content Claim: Carbohydrate Content of Foods
|
|
|
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
|
|
|
|
| 2004P-0223
|
| Whole Grain Descriptive Claims
|
|
|
|
|
| 2004P-0298
|
| Nutrient Content Claims for the Carbohydrate Content of Food
|
|
|
|
|
| 2004P-0299
|
| Nutrient Content Claims for Carbohydrates
|
|
|
|
|
| 2005D-0169
|
| Guidance on Useful Written Consumer Medication Information (CMI)
|
|
|
|
|
| 2005D-0183
|
| Guidance for Industry on Antiviral Drug Development Conducting Virology Studies and Submitting the Data to the Agency
|
|
|
|
|
| 2005D-0219
|
| Guidance for Industry: General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals
|
|
|
|
|
| 2005M-0283
|
| Premarket Approcal of VNS Theraphy System Cyberonics, Inc.P970003/S050, Approved 7/15/05
|
|
|
|
|
| 2005M-0284
|
| Onco-LIFE Endoscopic Light Source and Video Camera (Onco-LIFE) by Xillix Technologies Corp., P950042/S003, Approved 6/30/05
|
|
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
|
|
| 2005P-0037
|
| regarding product of estradiol vaginal cream
|
|
|
|
|
| 2005P-0116
|
| To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations
|
|
|
|
|
| 2005P-0277
|
| ANADA Suitability for generic version of EXCENEL RTU, ceftiofur hydrochloride sterile suspension
|
|
|
|
|
| 1996P-0230
|
| Grant exception for label declaration of ingredients/b olive
|
|
|
|
|
| MT
1
|
| HFS-822 to Hyman, Phelps & McNamara, P.C.
|
| Vol #:
|
| 1
|
|
| |
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutritin
|
|
|
|
|
| C
118
|
| United Egg Producers (UEP)
|
| Vol #:
|
| 9
|
|
|
|
|
| C
119
|
| Association for Dressings and Sauces (ADS)
|
| Vol #:
|
| 9
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| C
7500
|
| Voices for Animals
|
| Vol #:
|
| 319
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| C 12809
|
| Eric Skalwold
|
| Vol #:
|
| 806
|
|
|
|
|
| C 12810
|
| Jane Sorensen
|
| Vol #:
|
| 806
|
|
|
|
|
| C 12811
|
| Erin Riddle
|
| Vol #:
|
| 806
|
|
|
|
|
| C 12812
|
| Janet Correll
|
| Vol #:
|
| 806
|
|
| | | | | | | | |
|
|
|
|
| LET
5
|
| Grocery Manufacturers of America
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
|
|
|
|
| C
8
|
| Novartis Pharmaceuticals, Corporation
|
| Vol #:
|
| 2
|
|
| |
|
| 2004P-0223
|
| Whole Grain Descriptive Claims
|
|
|
|
|
| C
23
|
| Roman Meal Company
|
| Vol #:
|
| 5
|
|
|
|
|
| 2004P-0298
|
| Nutrient Content Claims for the Carbohydrate Content of Food
|
|
|
|
|
| LET
3
|
| Unilever United States Inc
|
| Vol #:
|
| 2
|
|
|
|
|
| 2004P-0299
|
| Nutrient Content Claims for Carbohydrates
|
|
|
|
|
| LET
3
|
| Frito-Lay Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0169
|
| Guidance on Useful Written Consumer Medication Information (CMI)
|
|
|
|
|
| C
2
|
| sanofi-aventis Group
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0183
|
| Guidance for Industry on Antiviral Drug Development Conducting Virology Studies and Submitting the Data to the Agency
|
|
|
|
|
| C
2
|
| Gilead Sciences, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0219
|
| Guidance for Industry: General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals
|
|
|
|
|
| C 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005M-0283
|
| Premarket Approcal of VNS Theraphy System Cyberonics, Inc.P970003/S050, Approved 7/15/05
|
|
|
|
|
| AAV
1
|
| Cyberonics, Inc.
|
| Vol #:
|
| 1
|
|
| |
|
| 2005M-0284
|
| Onco-LIFE Endoscopic Light Source and Video Camera (Onco-LIFE) by Xillix Technologies Corp., P950042/S003, Approved 6/30/05
|
|
|
|
|
| AAV
1
|
| Xillix Technologies Corp.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
|
|
| C
5
|
| Mylan Laboratories, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0037
|
| regarding product of estradiol vaginal cream
|
|
|
|
|
| LET
1
|
| HFD_005 to Warner Chilcott
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0116
|
| To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations
|
|
|
|
|
| C
1
|
| Rotech Healthcare, Inc.
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005P-0277
|
| ANADA Suitability for generic version of EXCENEL RTU, ceftiofur hydrochloride sterile suspension
|
|
|
|
|
| WDL
1
|
| Pfizer Animal Health
|
| Vol #:
|
| 1
|
|
